@article{d00f2793c5d045519751f9d0f3b9b94c,
title = "A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia",
author = "Prithviraj Bose and Srdan Verstovsek and Cortes, {Jorge E.} and Susan Tse and Yvonne Gasior and Nitin Jain and Jabbour, {Elias J.} and Zeev Estrov and Yesid Alvarado and DiNardo, {Courtney D.} and Naveen Pemmaraju and Kornblau, {Steven M.} and Kadia, {Tapan M.} and Daver, {Naval G.} and Kiran Naqvi and Short, {Nicholas J.} and Lucia Masarova and John Villareal and Pierce, {Sherry A.} and Graciela Nogueras-Gonzalez and Xuelin Huang and Guillermo Garcia-Manero and Kantarjian, {Hagop M.} and Farhad Ravandi",
note = "Funding Information: Acknowledgements This study was supported, in part, by Incyte Corporation and by the MD Anderson Cancer Center Support Grant from the National Cancer Institute (National Institutes of Health), P30 CA016672.",
year = "2020",
month = sep,
day = "1",
doi = "10.1038/s41375-020-0778-0",
language = "English (US)",
volume = "34",
pages = "2489--2492",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "9",
}